Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Entourage effect

From Wikipedia, the free encyclopedia
Proposed mechanism of cannabis compounds

Theentourage effect is a hypothesis thatcannabis compounds, other than thecannabinoidstetrahydrocannabinol (THC) andcannabidiol (CBD), act synergistically with cannabinoids to modulate the overall psychoactive effects of the plant.[1][2] The effect has also been applied in the case ofpsilocybin mushrooms, with other compounds besidespsilocybin having been hypothesized to also contribute to the effects of the mushrooms.[3]

Compounds

[edit]

Terpenes

[edit]

There are numerousterpenes present in the cannabis plant and variation in their contents between strains. Some terpenes are under preliminary research for their possible effects in vivo.[4][2][5] Various terpenes have been found to independently influence behavioral outcomes in mice, with simultaneous administration of CBD and terpene blends having a significantly greater impact than either substance administered independently.[6]

Hypothetical differences betweenC. indica andC. sativa

[edit]
  • Cannabinoid ratios: On average,Cannabis indica has higher levels ofTHC compared toCBD, whereasCannabis sativa has lower levels of THC to CBD.[7] However, huge variability exists within either species. A 2015 study shows the average THC content of the most popular herbal cannabis products in the Netherlands has decreased slightly since 2005.[8]
  • Terpene ratios: Sativa ancestry is associated withfarnesene andbergamotene, while Indica ancestry is associated withmyrcene,elemene, andsesquiterpene alcohols.[citation needed]

Criticism

[edit]

In 2022, studies found that plants identified as "indica" or "sativa" based on common methods of differentiation (e.g. plant height or leaf shape) are not, in fact, chemically distinguishable, with many identified as "sativa" having cannabinoid ratios predicted of "indica" plants and vice versa. The authors have concluded that the chemical makeup of cannabis plants cannot be reliably determined by simple inspection of the plants' physical characteristics and that the "indica" and "sativa" labels are not informative as to the cannabinoids (or other chemical components) delivered.[9][10]

Background

[edit]

The phraseentourage effect was introduced in 1999.[11][12] While originally identified as a novel method of endocannabinoid regulation by which multiple endogenous chemical species display a cooperative effect in eliciting a cellular response, the term has evolved to describe the polypharmacy effects of combined cannabis phytochemicals or whole plant extracts.[13] The phrase now commonly refers to the compounds present in cannabis purportedly working in concert to create "the sum of all the parts that leads to the magic or power of cannabis".[4] Other cannabinoids, terpenoids, and flavonoids may be part of an entourage effect.[12]

Criticism

[edit]

A 2020 review of research found no entourage effect in most studies, while other reports claimed mixed results, including the possibility of increasedadverse effects.[14] The review concluded that the term, "entourage effect", is unfounded and used mainly for marketing.[14]

References

[edit]
  1. ^Grof CP (November 2018)."Cannabis, from plant to pill".British Journal of Clinical Pharmacology.84 (11):2463–2467.doi:10.1111/bcp.13618.PMC 6177712.PMID 29701252.
  2. ^abRusso EB (August 2011)."Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects".British Journal of Pharmacology.163 (7):1344–64.doi:10.1111/j.1476-5381.2011.01238.x.PMC 3165946.PMID 21749363.
  3. ^Pepe M, Hesami M, de la Cerda KA, Perreault ML, Hsiang T, Jones AM (December 2023). "A journey with psychedelic mushrooms: From historical relevance to biology, cultivation, medicinal uses, biotechnology, and beyond".Biotechnol Adv.69 108247.doi:10.1016/j.biotechadv.2023.108247.PMID 37659744.Additionally, various compounds can collectively contribute to what is known as "the entourage effect", which describes the synergistic interaction of a variety of different metabolites that enhance the activity of the primary active components (Russo, 2019). Tryptamine concentrations and profiles across different Psilocybe species are highly variable. Thus, the diversity of Psilocybe species results in differential production of an assortment of tryptamines in different concentrations (Glatfelter et al., 2022), which is likely responsible for variable psychoactive effects of various mushrooms.
  4. ^abChen A (20 April 2017)."Some of the Parts: Is Marijuana's "Entourage Effect" Scientifically Valid?". Scientific American. Retrieved2017-12-31.
  5. ^LaVigne, Justin E.; Hecksel, Ryan; Keresztes, Attila; Streicher, John M. (15 April 2021)."Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity".Scientific Reports.11 (1): 8232.doi:10.1038/s41598-021-87740-8.PMC 8050080.PMID 33859287.
  6. ^Staben, J; Koch, M; Reid, K; Muckerheide, J; Gilman, L; McGuinness, F; Kiesser, S; Oswald, IW; Koby, KA; Martin, TJ; Kaplan, JS (15 June 2023)."Cannabidiol and cannabis-inspired terpene blends have acute prosocial effects in the BTBR mouse model of autism spectrum disorder".Frontiers in Neuroscience.17 1185737.doi:10.3389/fnins.2023.1185737.PMC 10311644.PMID 37397463.
  7. ^Karl W. Hillig; Paul G. Mahlberg (2004)."A chemotaxonomic analysis of cannabinoid variation inCannabis (Cannabaceae)".American Journal of Botany.91 (6):966–975.Bibcode:2004AmJB...91..966H.doi:10.3732/ajb.91.6.966.PMID 21653452.
  8. ^Niesink RJ, Rigter S, Koeter MW, Brunt TM (2015). "Potency trends of Δ9-tetrahydrocannabinol, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-15".Addiction.110 (12):1941–50.doi:10.1111/add.13082.PMID 26234170.
  9. ^Smith, Christiana J.; Vergara, Daniela; Keegan, Brian; Jikomes, Nick (2022)."The phytochemical diversity of commercial Cannabis in the United States".PLOS ONE.17 (5): –0267498.Bibcode:2022PLoSO..1767498S.doi:10.1371/journal.pone.0267498.ISSN 1932-6203.PMC 9119530.PMID 35588111.
  10. ^Murovec, Jana; Eržen, Jan Jurij; Flajšman, Marko; Vodnik, Dominik (2022)."Analysis of Morphological Traits, Cannabinoid Profiles, THCAS Gene Sequences, and Photosynthesis in Wide and Narrow Leaflet High-Cannabidiol Breeding Populations of Medical Cannabis".Frontiers in Plant Science.13 786161.Bibcode:2022FrPS...1386161M.doi:10.3389/fpls.2022.786161.ISSN 1664-462X.PMC 8907982.PMID 35283868.
  11. ^Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, et al. (July 1998). "An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity".European Journal of Pharmacology.353 (1):23–31.doi:10.1016/s0014-2999(98)00392-6.PMID 9721036.
  12. ^abGupta S (11 March 2014)."Medical marijuana and "the entourage effect"".CNN. Retrieved31 December 2017.
  13. ^Russo EB (2019-01-09)."The Case for the Entourage Effect and Conventional Breeding of Clinical Cannabis: No "Strain," No Gain".Frontiers in Plant Science.9: 1969.Bibcode:2019FrPS....9.1969R.doi:10.3389/fpls.2018.01969.PMC 6334252.PMID 30687364.
  14. ^abCogan PS (August 2020). "The "entourage effect" or "hodge-podge hashish": the questionable rebranding, marketing, and expectations of cannabis polypharmacy".Expert Review of Clinical Pharmacology.13 (8):835–845.doi:10.1080/17512433.2020.1721281.PMID 32116073.S2CID 211726166.
General
Usage
General
Hemp
Variants
Effects
Culture
Organizations
Cannabis rights
Science
Demographics
Politics
General
Major legal
reforms
Politicians
and parties
Legal cases
Related
Phytocannabinoids
(comparison)
Cannabibutols
Cannabichromenes
Cannabicyclols
Cannabidiols
Cannabielsoins
Cannabigerols
Cannabiphorols
Cannabinols
Cannabitriols
Cannabivarins
Delta-3-tetrahydrocannabinols
Delta-4-tetrahydrocannabinols
Delta-7-tetrahydrocannabinols
Delta-8-tetrahydrocannabinols
Delta-9-tetrahydrocannabinols
Delta-10-Tetrahydrocannabinols
Delta-11-Tetrahydrocannabinols
Miscellaneous cannabinoids
Active metabolites
Endocannabinoids
Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Classical cannabinoids
(dibenzopyrans)
Non-classical
cannabinoids
Adamantoylindoles
Benzimidazoles
Benzoylindoles
Cyclohexylphenols
Eicosanoids
Indazole-3-
carboxamides
Indole-3-carboxamides
Indole-3-carboxylates
Naphthoylindazoles
Naphthoylindoles
Naphthoylpyrroles
Naphthylmethylindenes
Naphthylmethylindoles
Phenylacetylindoles
Pyrazolecarboxamides
Tetramethylcyclo-
propanoylindazoles
Tetramethylcyclo-
propanoylindoles
Others
AllostericCBRTooltip Cannabinoid receptorligands
Endocannabinoid
enhancers

(inactivation inhibitors)
Anticannabinoids
(antagonists/inverse
agonists/antibodies)
Receptor
(ligands)
CB1Tooltip Cannabinoid receptor type 1
Agonists
(abridged,
full list)
Inverse agonists
Antagonists
CB2Tooltip Cannabinoid receptor type 2
Agonists
Antagonists
NAGly
(
GPR18)
Agonists
Antagonists
GPR55
Agonists
Antagonists
GPR119
Agonists
Transporter
(modulators)
eCBTsTooltip Endocannabinoid transporter
Enzyme
(modulators)
FAAHTooltip Fatty acid amide hydrolase
MAGL
ABHD6
ABHD12
Others
  • Others:2-PG(directly potentiates activity of 2-AG at CB1 receptor)
  • ARN-272(FAAH-like anandamide transporter inhibitor)
See also
Receptor/signaling modulators
Cannabinoids (cannabinoids by structure)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Entourage_effect&oldid=1338413710"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2026 Movatter.jp